Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
JAMA Oncology|July 31, 2025
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk GroupNeal A Patel, Daniel A Barocas, Daniel W Lin, et al.
American Journal of Epidemiology|May 5, 2011
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Kathryn B Arnold, et al.
CA: a Cancer Journal for Clinicians|February 22, 2017
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manualMark K Buyyounouski, Peter L Choyke, Jesse K McKenney, et al.
The Journal of Biological Chemistry|May 31, 2002
Evidence that the human gene for prostate short-chain dehydrogenase/reductase (PSDR1) encodes a novel retinal reductase (RalR1)Natalia Y Kedishvili, Olga V Chumakova, Sergei V Chetyrkin, et al.
Urology|September 18, 2009
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepositoryLisa F Newcomb, James D Brooks, Peter R Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patientsRalf Kurek, German Nunez, Nikolaos Tselis, et al.
Advances in Therapy|June 17, 2025
Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate CancerMehmet A Bilen, Sabree Burbage, Carmine Rossi, et al.
Urology|July 23, 2015
Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy EraLiam C Macleod, Scott S Tykodi, Sarah K Holt, et al.
The Prostate|November 26, 2009
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention TrialAlan R Kristal, Douglas K Price, Cathee Till, et al.
The American Journal of Surgical Pathology|February 15, 2014
Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrenceJason P Izard, Lawrence D True, Philip May, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
JAMA Oncology|July 31, 2025
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk GroupNeal A Patel, Daniel A Barocas, Daniel W Lin, et al.
American Journal of Epidemiology|May 5, 2011
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Kathryn B Arnold, et al.
CA: a Cancer Journal for Clinicians|February 22, 2017
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manualMark K Buyyounouski, Peter L Choyke, Jesse K McKenney, et al.
The Journal of Biological Chemistry|May 31, 2002
Evidence that the human gene for prostate short-chain dehydrogenase/reductase (PSDR1) encodes a novel retinal reductase (RalR1)Natalia Y Kedishvili, Olga V Chumakova, Sergei V Chetyrkin, et al.
Urology|September 18, 2009
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepositoryLisa F Newcomb, James D Brooks, Peter R Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patientsRalf Kurek, German Nunez, Nikolaos Tselis, et al.
Advances in Therapy|June 17, 2025
Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate CancerMehmet A Bilen, Sabree Burbage, Carmine Rossi, et al.
Urology|July 23, 2015
Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy EraLiam C Macleod, Scott S Tykodi, Sarah K Holt, et al.
The Prostate|November 26, 2009
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention TrialAlan R Kristal, Douglas K Price, Cathee Till, et al.
The American Journal of Surgical Pathology|February 15, 2014
Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrenceJason P Izard, Lawrence D True, Philip May, et al.
Pageof 29